Literature DB >> 16373603

Lipoprotein-associated phospholipase A2 and measures of extracoronary atherosclerosis: the Rotterdam Study.

Isabella Kardys1, Hok-Hay S Oei, Irene M van der Meer, Albert Hofman, Monique M B Breteler, Jacqueline C M Witteman.   

Abstract

OBJECTIVE: Lipoprotein-associated phospholipase A2 (Lp-PLA2) may be a new and independent predictor of cardiovascular events. The effect of Lp-PLA2 may be exerted through effects of the enzyme on the development of atherosclerosis. Therefore, we investigated the association between Lp-PLA2 activity and measures of extracoronary atherosclerosis. METHODS AND
RESULTS: Lp-PLA2 activity was determined in a random sample of 1820 participants from the Rotterdam Study, a population-based cohort study in men and women > or =55 years. Common carotid intima-media thickness, carotid plaques, ankle-arm index, and aortic calcification were examined. Atherosclerosis status could be assigned in 1609 participants. The age-adjusted odds ratio of having atherosclerosis at any site for the highest versus the lowest tertile of Lp-PLA2 activity was 1.86 (95% CI, 1.01 to 3.43) in men and 1.60 (95% CI, 1.08 to 2.37) in women. After additional adjustment for cholesterol, these associations attenuated or even disappeared. The odds ratios of having atherosclerosis at specific sites (carotid arteries and aortic-iliac-femoral tract) followed a similar pattern.
CONCLUSIONS: Although Lp-PLA2 has been found to be independently associated with cardiovascular events, the association with measures of subclinical extracoronary atherosclerosis found in this study strongly attenuated or even disappeared after adjustment for cholesterol.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16373603     DOI: 10.1161/01.ATV.0000201289.83256.cf

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  28 in total

1.  Assessing inflammatory status in cardiovascular disease.

Authors:  Dimitris Tousoulis; Charalambos Antoniades; Christodoulos Stefanadis
Journal:  Heart       Date:  2007-08       Impact factor: 5.994

2.  Lipoprotein-associated phospholipase A2 and risk of incident cardiovascular disease in a multi-ethnic cohort: The multi ethnic study of atherosclerosis.

Authors:  Parveen K Garg; Robyn L McClelland; Nancy S Jenny; Michael H Criqui; Philip Greenland; Robert S Rosenson; David S Siscovick; Neal Jorgensen; Mary Cushman
Journal:  Atherosclerosis       Date:  2015-05-16       Impact factor: 5.162

3.  Impact of atorvastatin treatment on platelet-activating factor acetylhydrolase and 15-F(2trans)-isoprostane in hypercholesterolaemic patients.

Authors:  Ghainsom D Kom; Edzard Schwedhelm; Renke Maas; Lydia Schneider; Ralf Benndorf; Rainer H Böger
Journal:  Br J Clin Pharmacol       Date:  2007-01-03       Impact factor: 4.335

4.  Serum lipid changes following the onset of depressive symptoms in postmenopausal women.

Authors:  Jane E Persons; Jennifer G Robinson; Martha E Payne; Jess G Fiedorowicz
Journal:  Psychiatry Res       Date:  2016-12-05       Impact factor: 3.222

5.  Association of carotid plaque Lp-PLA(2) with macrophages and Chlamydia pneumoniae infection among patients at risk for stroke.

Authors:  Berna Atik; S Claiborne Johnston; Deborah Dean
Journal:  PLoS One       Date:  2010-06-09       Impact factor: 3.240

6.  Lipoprotein-associated phospholipase A2 activity and incident coronary heart disease among men and women with type 2 diabetes.

Authors:  Ida J Hatoum; Frank B Hu; Jeanenne J Nelson; Eric B Rimm
Journal:  Diabetes       Date:  2010-02-25       Impact factor: 9.461

7.  Enhanced expression of Lp-PLA2 and lysophosphatidylcholine in symptomatic carotid atherosclerotic plaques.

Authors:  Dallit Mannheim; Joerg Herrmann; Daniele Versari; Mario Gössl; Fredric B Meyer; Joseph P McConnell; Lilach O Lerman; Amir Lerman
Journal:  Stroke       Date:  2008-03-20       Impact factor: 7.914

8.  Systematic Review of the Association between Lipoprotein-Associated Phospholipase A2 and Atherosclerosis.

Authors:  Jing Liu; Yuling Hong; Yue Qi; Fan Zhao; Dong Zhao
Journal:  N Am J Med Sci (Boston)       Date:  2011-10

9.  Longitudinal study of low serum LDL cholesterol and depressive symptom onset in postmenopause.

Authors:  Jane E Persons; Jennifer G Robinson; William H Coryell; Martha E Payne; Jess G Fiedorowicz
Journal:  J Clin Psychiatry       Date:  2016-02       Impact factor: 4.384

10.  Identification of a domain that mediates association of platelet-activating factor acetylhydrolase with high density lipoprotein.

Authors:  Alison A Gardner; Ethan C Reichert; Matthew K Topham; Diana M Stafforini
Journal:  J Biol Chem       Date:  2008-04-22       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.